Anaplastic thyroid carcinomas
Clinical trials for Anaplastic thyroid carcinomas explained in plain language.
Never miss a new study
Get alerted when new Anaplastic thyroid carcinomas trials appear
Sign up with your email to follow new studies for Anaplastic thyroid carcinomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy targets Hard-to-Treat cancers
Disease control PausedThis early-stage trial tests a new type of immunotherapy called CD70-targeted CAR-T cells in people with advanced solid tumors, including kidney, lung, ovarian, and thyroid cancers. The treatment involves taking a patient's own immune cells, engineering them to recognize and atta…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase 1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New immunotherapy combo targets rare cancers left behind by progress
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs, domvanalimab and zimberelimab, in people with five types of advanced rare cancers (peritoneal mesothelioma, gestational trophoblastic tumor, anaplastic thyroid carcinoma, neuroendocrine tumors, and thymic carcinom…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC